Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01518049 |
Recruitment Status
:
Completed
First Posted
: January 25, 2012
Last Update Posted
: October 14, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.
Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.
Condition or disease |
---|
Affective Disorders, Psychotic |
Study Type : | Observational |
Actual Enrollment : | 50 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Study Start Date : | February 2012 |
Actual Primary Completion Date : | September 2013 |
Actual Study Completion Date : | September 2014 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Fulfilling ICD-10 criteria DF32.3 or DF33.3
- At least 18 years old
- Legally competent
- Informed consent (oral & written)
Exclusion Criteria:
- Insufficient Danish Language skills
- Moderate to severe dementia
- Abuse of psychoactive substances

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01518049
Denmark | |
Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital | |
Aalborg, Denmark, 9000 |
Principal Investigator: | Søren D Østergaard, MD | Aahus University Hospital |
Publications of Results:
Responsible Party: | Søren Dinesen Østergaard, Principal Investigator, Aarhus University Hospital |
ClinicalTrials.gov Identifier: | NCT01518049 History of Changes |
Other Study ID Numbers: |
N-20110029 |
First Posted: | January 25, 2012 Key Record Dates |
Last Update Posted: | October 14, 2015 |
Last Verified: | October 2015 |
Keywords provided by Søren Dinesen Østergaard, Aarhus University Hospital:
Affective Disorders, Psychotic Psychometrics Biological Markers |
Additional relevant MeSH terms:
Mental Disorders Psychotic Disorders Mood Disorders Affective Disorders, Psychotic Schizophrenia Spectrum and Other Psychotic Disorders |